JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M211719200 on August 11, 2003

J. Biol. Chem., Vol. 278, Issue 45, 44033-44040, November 7, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/45/44033    most recent
M211719200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boorman, J. P.
Right arrow Articles by Sivilotti, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boorman, J. P.
Right arrow Articles by Sivilotti, L. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Effects of {beta}3 Subunit Incorporation on the Pharmacology and Single Channel Properties of Oocyte-expressed Human {alpha}3{beta}4 Neuronal Nicotinic Receptors*

James P. Boorman{ddagger}, Marco Beato§, Paul J. Groot-Kormelink§, Steven D. Broadbent§, and Lucia G. Sivilotti§

From the Department of Pharmacology, The School of Pharmacy, 29/39 Brunswick Square, London, WC1N 1AX United Kingdom

We compared the main properties of human recombinant {alpha}3{beta}4{beta}3 neuronal nicotinic receptors with those of {alpha}3{beta}4 receptors, expressed in Xenopus oocytes. {beta}3 incorporation decreased the channel mean open time (from 5.61 to 1.14 ms, after approximate correction for missed gaps) and burst length. There was also an increase in single channel slope conductance from 28.8 picosiemens ({alpha}3{beta}4) to 46.7 picosiemens ({alpha}3{beta}4{beta}3; in low divalent external solution). On the other hand, the calcium permeability (determined by a reversal potential method in chloride-depleted oocytes) and the pharmacological properties of {beta}3-containing receptors differed little from those of {alpha}3{beta}4. The main pharmacological difference in {alpha}3{beta}4{beta}3 "triplet" receptors was a 3-fold decrease in the potency of lobeline relative to acetylcholine. Nevertheless, there was no change in the rank order of potency for agonists (epibatidine >> lobeline > cytisine, 1,1-dimethyl-4-phenylpiperazinium iodide, nicotine > acetylcholine > carbachol for both receptors; measured at low agonist concentrations). Sensitivity to the competitive antagonists trimetaphan (0.2–1 µM) and dihydro-{beta}-erythroidine (30 µM) was similar for the two combinations, with a Schild KB for trimetaphan of 76 and 66 nM on {alpha}3{beta}4 and {alpha}3{beta}4{beta}3, respectively. The change in single channel conductance confirms that {beta}3 replaces a {beta}4 subunit in the pentamer. The absence of pronounced differences in the pharmacological profile of the triplet receptor argues against a role for the {beta}3 subunit in the formation of agonist binding sites, whereas the changes in channel kinetics suggest an important effect on receptor gating. The shortening of the burst length of {beta}3-containing receptors implies that any synaptic currents mediated by such channels would have faster decay kinetics.


Received for publication, November 18, 2002 , and in revised form, July 24, 2003.

* This work was supported by Wellcome Trust Project Grants 055524 and 064652, Medical Research Council Cooperative Grant G9819400 Ph.D. studentship (to S. D. B.), and a School of Pharmacy Millennium Ph.D. Studentship (to J. P. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Current address: Dept. of Biology, University College London, London WC1E 6BT, UK.

§ Current address: Dept. of Pharmacology, University College of London, London WC1E 6BT, UK.

To whom correspondence should be addressed. Tel.: 44-20-7679-3693; Fax: 44-20-7679-7298; E-mail: l.sivilotti{at}ucl.ac.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
R. M. Drenan, R. Nashmi, P. Imoukhuede, H. Just, S. McKinney, and H. A. Lester
Subcellular Trafficking, Pentameric Assembly, and Subunit Stoichiometry of Neuronal Nicotinic Acetylcholine Receptors Containing Fluorescently Labeled {alpha}6 and 3 Subunits
Mol. Pharmacol., January 1, 2008; 73(1): 27 - 41.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Broadbent, P. J. Groot-Kormelink, P. A. Krashia, P. C. Harkness, N. S. Millar, M. Beato, and L. G. Sivilotti
Incorporation of the beta3 Subunit Has a Dominant-Negative Effect on the Function of Recombinant Central-Type Neuronal Nicotinic Receptors
Mol. Pharmacol., October 1, 2006; 70(4): 1350 - 1357.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. J. Groot-Kormelink, S. Broadbent, M. Beato, and L. G. Sivilotti
Constraining the Expression of Nicotinic Acetylcholine Receptors by Using Pentameric Constructs
Mol. Pharmacol., February 1, 2006; 69(2): 558 - 563.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.